At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 12 Feb 2001 Profile reviewed but no significant changes made
- 08 Nov 1994 No-Development-Reported for Cancer in United Kingdom (Unknown route)